購物車
幫助
021-54845833/15800441009
|
Background: |
Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. |
|
Applications: |
ELISA, WB, IHC |
|
Name of antibody: |
DCK |
|
Immunogen: |
Fusion protein of human DCK |
|
Full name: |
deoxycytidine kinase |
|
SwissProt: |
P27707 |
|
ELISA Recommended dilution: |
1000-2000 |
|
IHC positive control: |
Human tonsil |
|
IHC Recommend dilution: |
25-100 |
|
WB Predicted band size: |
31 kDa |
|
WB Positive control: |
Mouse heart tissue |
|
WB Recommended dilution: |
200-1000 |
